1.gif (1892 bytes)

Case Reports

Indian Pediatrics 2007;44:-779-781 

Femoral Venous Thrombosis in a 5-week Old with Diabetic Ketoacidosis and a Femoral Venous Catheter

 

Sarah L. Woolley
David R. K. Smith

 

From the Emergency Department, Bristol Royal Hospital for Children, Bristol BS2 8BJ, UK; and University Hospital of Wales, Heath Park, Cardiff, CF14 4XW, UK.

Correspondence to: Dr. Sarah L. Woolley, Bristol Royal Hospital for Children, Bristol BS2 8BJ, UK. E-mail: [email protected]

Manuscript received: July 3, 2006; Initial review completed: September 28, 2006;
Revision accepted: April 25, 2007.

Abstract:

Children with diabetic ketoacidosis (DKA) may require central venous catheters (CVC) for fluid resuscitation. CVC-related thrombus has been reported in a variety of conditions but only rarely in association with DKA and never in a child under one. The case of a five week old child with DKA and a CVC-related thrombus is presented.

Key words: Central venous catheter, Diabetic keto-acidosis, Venous thromboembolism.

Children with DKA may require central venous access for resuscitation purposes. This route of vascular access, however, is associated with a variety of complications(1) including venous thromboembolism (VTE)(2). Whilst children with thrombophilia, malignancy, congenital cardiac disease, acute infection, trauma and surgery are known to be at high risk from central venous catheter (CVC) related VTE(1), few cases have been reported in association with DKA(3,4) and no cases have been reported in a child under one. We report the case of a five-week-old child with DKA who developed a femoral DVT following insertion of a femoral CVC for fluid resuscitation. The literature surrounding DKA and CVC-related VTE is reviewed.

Case Report

A five-week-old Somalian boy was brought to the Emergency Department (ED) with a 24 hour history of being non-specifically unwell, off his feeds and vomiting. A diagnosis of viral illness had been made twelve hours prior to his attendance. However, overnight he had become increasingly unwell and was brought to the ED by his parents. He was born at term with a birth weight of 3.87 kg and had been previously well. His parents and 3-year-old brother were all well.

On examination he was a febrile, irritable, tachypneic (rate 36 breaths/minute), tachycardic (170 beats/minute), drowsy and approximately 10% dehydrated (estimated by a sunken fontanel, sunken eyes and reduced skin turgor). An initial venous blood gas revealed: pH 6.99, CO2 21.2 mmHg, base deficit 25.6 mmol/L, bicarbonate 5.7 mmol/L, lactate 2.4 mmol/L, sodium 153 mmol/L, potassium 5.3 mmol/L and glucose 45 mmol/L. These results were confirmed in the laboratory. A diagnosis of DKA was made; a femoral CVC was inserted, and the infant was treated with intravenous fluids and insulin according to local guidelines and transferred to the pediatric intensive care unit (PICU). Fluid resuscitation occurred over 48 hours ensuring that serum sodium and osmolarity did not alter rapidly. Acidosis and ketonuria ceased within 36 hours.

Four days after admission he was transferred to the ward. On removal of the left femoral CVC it was noted that his left leg was swollen. An ultrasound scan (USS) demonstrated an extensive left femoral vein thrombosis extending to the lower left thigh. He was commenced on Clexane® which continued until an USS demonstrated clot resolution six weeks later.

Discussion

In children with critical illness requiring fluid and other medication, a CVC may be the only vascular access obtainable. VTE is a known complication with pediatric VTE registries reporting that 28-50% of VTE episodes in children are CVC-related(5,6). The reported incidence in PICU varies according to whether the diagnosis is made clinically or radiologically, with one study suggesting an incidence of 18.3% based on radiological diagnosis(2).

In children, the majority of cases of CVC-related thrombosis occur in association with malignancy, congenital cardiac disease, acute infection, short gut syndrome, renal disease, thombophilias and trauma(1). Whilst DKA has not been identified as an isolated risk factor for CVC-related VTE, in adult(7). Additionally, two recent studies(3,4) suggest that DKA may predispose children to the development of CVC-related VTE.

Gutierrez’s retrospective case-control study(3) looked specifically at children admitted to PICU with DKA who had femoral CVC insertion. Each child was age-matched with two controls consecutively selected from a database of CVC placements. All controls had femoral CVC insertion for shock (defined by the authors as arterial hypotension, requirement of 40 mL/kg fluid resuscitation or the need for inotropes/vasopressors). Children with known risk factors for CVC-related VTE were excluded. Eight children out of 154 with DKA required a femoral CVC. Four children, all under three years of age with normal thrombophilia screens, developed CVC-related VTE. None of the sixteen control patients did (P = 0.007). The authors concluded that young children with DKA requiring femoral CVC placement are at an increased risk of developing CVC-related VTE.

Worly, et al.(4) retrospective cohort study found similar results and the authors reached similar conclusions. Six out of 113 children admitted to PICU with DKA required a femoral CVC. Three developed CVC-related VTE. In comparison, only six out of 413 non-DKA children with femoral CVCs developed CVC-related VTE (P<0.001). All three children were under two years of age and developed signs within 48 hours of CVC insertion. Subsequent thrombophilia screens were un-remarkable.

Femoral CVCs may increase the risk of VTE in children with DKA for a number of reasons: DKA-associated dehydration may increase the risk of VTE. Dehydration, however, has never been implicated specifically as causative in either adults or children and Gutierrez, et al.(3) specifically report that there was no difference in hydration between children with DKA/VTE and the controls; platelet aggregability increases in the presence of hyperglycemia(7), possibly as a result of reduced nitrous oxide availability; hyperglycaemia and acidosis increase red cell rigidity which in turn increases viscous resistance and impairs blood flow [8]; in adults hyperglycaemia is associated with hyperfibrinogenemia and hyperviscosity(9); and the hyperosmolarity associated with DKA may contribute(8).

The number of reported cases of CVC-related VTE in association with DKA is small. This complication, however, may have life-threatening complications. Whilst evidence is limited and further studies are needed, the judicious use of femoral CVCs, particularly in children under three years of age with DKA is recommended. Where essential for resuscitation purposes, these lines should be removed as soon as possible, particularly as CVC-related VTE appears to occur within the first 24-48 hours after insertion.

Contributors: Both authors contributed to case-management, review of literature and manuscript drafting.

Funding: None.

Competing interests: None stated.

 

 References


1. Massicotte M, Dix D, Monagle P, Adams M, Andrew M. Central venous catheter related thrombosis in children: analysis of the Canadian Registry of Venous Thromboembolic Complications. J Pediatr 1998; 133: 770-776.

2. Beck C, Dubois J, Grigon A, Lacroix J, David M. Incidence and risk factors of catheter-related deep vein thrombosis in a pediatric intensive care unit: a prospective study. J Pediatr 1998; 133: 237-241.

3. Gutierrez JA, Bagatelle R, Samson MP, Theodorou AA, Berg RA. Femoral central venous catheter-associated deep venous thrombosis in children with diabetic ketoacidosis. Crit Care Med 2003; 31: 80-83.

4. Worly JM, Fortenberry JD, Hansen I, Chambliss CR, Stockwell J. Deep Venous Thrombosis in Children with Diabetic Ketoacidosis and Femoral Central Venous Catheters. Pediatrics 2004;113: e57-60.

5. David M, Andrew M. Venous thromboembolism complications in children: a critical review of the literature. J Pediatr 1993; 123: 337-346.

6. van Ommen CH, Heijboer H, Buller HR, Hirasing RA, Heijmans HS, Peters M. Venous thrombo-embolism in childhood: A prospective two-year registry in the Netherlands. J Pediatr 2001; 39: 676-681.

7. Carr ME. Diabetes mellitus: A hypercoaguable state. J Diabetes Complications 2001; 15: 44-54.

8. Evan-Wong LA, Davidson RJ, Stowers JM. Alterations in erythrocytes in hyperosmolar diabetic compensation: a pathophysiological basis for impaired blood flow and for improved design of fluid therapy. Diabetologica 1985; 28: 739-742.

9. Reid HL, Vigilance J, Wright-Pascoe RA, Choo-Kang E. The influence of persistent hyperglycaemia on hyperfibrinogenaemia and hyperviscosity in diabetes mellitus. West Indian Med J 2000; 49 : 281-284.

Home

Past Issue

About IP

About IAP

Feedback

Links

 Author Info.

  Subscription